# US 2018/0021374 A1 · Antibacterial Clay Compositions for Use as a Topical Ointment

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0021374 A1
- Document ID: US20180021374A1
- Status: Published application
- Kind: A1
- Application number: 15/216,940
- Filed: 2016-07-22
- Published: 2018-01-25
- Earliest claimed: 2016-07-22
- Applicants: Bishopsgate Exploration Ltd.
- Inventors: Tim Tuba
- Web page: https://patentgrep.com/patent/US20180021374A1

## CPC

- A61K 33/26: Iron; Compounds thereof
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 33/06: Aluminium, calcium or magnesium; Compounds thereof {, e.g. clay}
- A61K 47/02: Inorganic compounds
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The present invention is directed to synthetic bactericidal compositions having clay like properties and a method of using these compositions to topically treat bacterially-caused skin infections and skin diseases. The compositions within the scope of the invention comprise a bactericidal effective amount of a reducing agent, such as pyrite, marcasite, pyrrhotite, FeS2, FeS, FeSO4—or other reducing agents having like properties, and a natural clay or clay mineral and/or synthetic clay or clay mineral, or other suitable materials having clay-like properties with a high (>10) or low (<5) pH. The synthetic bactericidal compositions are synthesized by adding the reducing agent to the either high (>10) or low (<5) pH clay or clay mineral. It is the presence of both the reducing agent and the high (>10) or low (<5) pH clay of said compositions which renders them bactericidal.

## Claims

### Claim 1

A synthetic bactericidal composition for use in promotion of healing of a bacterial infection on the skin of a patient, comprising a bactericidal effective amount of a particulate reducing agent selected from the group consisting of pyrite, marcasite, pyrrhotite, FeS2, FeS, FeSO4, and a combination thereof, and a high (>10) or low (<5) pH clay or clay mineral comprising a smectite clay, an illite clay, a rectorite clay, or a combination thereof.

### Claim 2 (depends on 1)

The composition of claim 1, wherein said fine particulate reducing agent is present in said composition in an amount ranging from approximately 0.5% wt. to 10% wt. of said composition

### Claim 3 (depends on 1)

The composition of claim 1, wherein the particle size of said reducing agent is less than 1 micron.

### Claim 4 (depends on 1)

The composition of claim 1, wherein said reducing agent is pyrite, and wherein said clay is a smectite clay.

### Claim 5 (depends on 4)

The composition of claim 4, wherein said composition comprises 0.5% wt. to 10% wt. fine particulate pyrite; and wherein the particle size of said pyrite is less than one micron.

### Claim 5 (depends on 4)

The composition of claim 4, containing a suitable aqueous liquid in an amount so as to create a paste.

### Claim 6 (depends on 5)

The composition of claim 5, wherein said paste is arranged to be topically applied to the site of said bacterial skin infection.

### Claim 7

A method of promoting healing of a bacterial skin infection on the skin of a patient, comprising topically applying to said bacterial skin infection a composition comprising a bactericidal effective amount of a particulate reducing agent selected from the group consisting of pyrite, marcasite, pyrrhotite, FeS2, FeS, FeSO4, and a combination thereof, and a high (>10) or low (<5) pH clay or clay mineral comprising a smectite clay, an illite clay, a rectorite clay, or a combination thereof.

### Claim 8 (depends on 7)

The method of claim 7 comprising adding to the composition a suitable aqueous liquid in an amount so as to create a paste.

### Claim 9 (depends on 8)

The method of claim 8 comprising topically applying said hydrated composition to the site of said bacterial skin infection.

### Claim 10 (depends on 8)

The method of claim 8 wherein said suitable aqueous liquid is water.

### Claim 11 (depends on 7)

The method of claim 7, wherein said bacterial skin infection is caused by one or more bacteria selected from the group consisting of Mycobacterium ulcerans, E. coli, ESBL E. coli, Pseudomonas aeruginosa, Salmonella typhimurium, Staphylococcus epidermidis, S. aureus, MRSA, M. smegmatis, Streptococcus sp. and M. marinum.

### Claim 12 (depends on 7)

The method of claim 7, wherein said fine particulate reducing agent is present in said composition in an amount ranging from approximately 0.5% wt. to 10% wt. of said composition

### Claim 13 (depends on 7)

The method of claim 7, wherein the particle size of said reducing agent is less than 1 micron.

### Claim 14 (depends on 7)

The method of claim 7, wherein said reducing agent is pyrite, and wherein said clay is a smectite clay.

### Claim 15 (depends on 14)

The method of claim 14, wherein said composition comprises 0.5% wt. to 10% wt. fine particulate pyrite; and wherein the particle size of said pyrite is less than one micron.

### Claim 16 (depends on 7)

The method of claim 7, wherein the synthetic antibacterial clay or clay mineral is produced by: synthesizing a clay or clay mineral or by treating or altering the chemistry of a natural clay or clay mineral to yield a synthetic antibacterial clay or clay mineral containing within its crystal structure or within its exchange positions an antibacterial effective amount of a reducing agent; wherein said reducing agent ferrous iron and renders said clay or clay mineral antibacterial.
